SMO ClinPlus Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 4,372

Employees

  • Stock Symbol
  • 301257

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $5.08
  • (As of Friday Closing)

SMO ClinPlus General Information

Description

SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies, and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 23rd Floor, World Trade Building
  • 500 Guangdong Road, Huangpu District
  • Shanghai, 200001
  • China
+86 021
Primary Industry
Laboratory Services (Healthcare)
Stock Exchange
SHE
Corporate Office
  • 23rd Floor, World Trade Building
  • 500 Guangdong Road, Huangpu District
  • Shanghai, 200001
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SMO ClinPlus Stock Performance

As of 13-Nov-2026, SMO ClinPlus’s stock price is $5.08. Its current market cap is $401M with 79M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.08 $5.27 $4.54 - $12.18 $401M 79M 3.88M $0.05

SMO ClinPlus Financials Summary

As of 30-Sep-2026, SMO ClinPlus has a trailing 12-month revenue of $119M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 417,791 496,717 174,499 421,969
Revenue 118,925 117,156 112,011 107,428
EBITDA 5,885 19,628 18,348 23,261
Net Income 4,302 15,246 14,832 19,043
Total Assets 226,589 220,664 195,836 192,819
Total Debt 324 617 900 1,563
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SMO ClinPlus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SMO ClinPlus‘s full profile, request access.

Request a free trial

SMO ClinPlus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SMO ClinPlus Investments (2)

SMO ClinPlus’s most recent deal was a Later Stage VC with Oceanus Plus. The deal was made on 01-Apr-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Oceanus Plus 01-Apr-2020 Later Stage VC Enterprise Systems (Healthcare)
Oceanus Plus 27-Feb-2019 Later Stage VC Enterprise Systems (Healthcare)
To view SMO ClinPlus’s complete investments history, request access »

SMO ClinPlus ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view SMO ClinPlus’s complete esg history, request access »

SMO ClinPlus FAQs

  • When was SMO ClinPlus founded?

    SMO ClinPlus was founded in 2013.

  • Where is SMO ClinPlus headquartered?

    SMO ClinPlus is headquartered in Shanghai, China.

  • What is the size of SMO ClinPlus?

    SMO ClinPlus has 4,372 total employees.

  • What industry is SMO ClinPlus in?

    SMO ClinPlus’s primary industry is Laboratory Services (Healthcare).

  • Is SMO ClinPlus a private or public company?

    SMO ClinPlus is a Public company.

  • What is SMO ClinPlus’s stock symbol?

    The ticker symbol for SMO ClinPlus is 301257.

  • What is the current stock price of SMO ClinPlus?

    As of 13-Nov-2026 the stock price of SMO ClinPlus is $5.08.

  • What is the current market cap of SMO ClinPlus?

    The current market capitalization of SMO ClinPlus is $401M.

  • What is SMO ClinPlus’s current revenue?

    The trailing twelve month revenue for SMO ClinPlus is $119M.

  • What is SMO ClinPlus’s annual earnings per share (EPS)?

    SMO ClinPlus’s EPS for 12 months was $0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process